Bush Tia L
Chief Technology & Quality Ofc
Bush Tia L has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 24, 2026.
On the most recent filing, Bush Tia L is listed as Chief Technology & Quality Ofc at Centessa Pharmaceuticals plc. Inside the rolling window, Bush Tia L reported no open-market purchases and 2 open-market sales totaling $2.2M in CNTA. The largest disclosed transaction in the window is a sale of 40,000 CNTA shares on Nov 17, 2025, worth $1.1M.
Companies traded
Other insiders at CNTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Bush Tia L made?
Bush Tia L has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Bush Tia L trade?
Bush Tia L has filed SEC Form 4 disclosures for 1 company, including CNTA.
When was Bush Tia L's most recent SEC Form 4 filing?
Bush Tia L's most recent SEC Form 4 filing on Tracefour is dated Jun 24, 2026.
What is Bush Tia L's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bush Tia L is listed as Chief Technology & Quality Ofc.
What is Bush Tia L's total buy and sell value in the current window?
Inside the rolling retention window, Bush Tia L bought $0 and sold $2.2M based on SEC Form 4 filings.
What was Bush Tia L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 40,000 CNTA shares on 2025-11-17, worth $1.1M, per SEC Form 4 filings.